Drugs / Autologous NK cell therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03948828 | Jun 2019 → May 2022 | endometriosis | Shenzhen People's Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous NK cell therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03948828 ↗ |
| Modality | Cell therapy | “Biological: Autologous NK cell therapy” NCT03948828 ↗ |